Skip to main content

EULAR Best Abstracts - Day 2

The second day of EULAR 2021 took a big leap in online content.  #EULAR2021 generated 2500 tweets yesterday. Here is a compilation (with links) of presentations were the “Best” as seen by our RheumNow faculty. 

  1. Dr Mariette on BEL+RTX combo phase 2 RCT in Sjogrens. Safety ok. Trend to improvement in ESSDAI and stimulated salivary flow. B-cell depletion in salivary gland biopsies   Abstr#OP0135   @RichardPAConway

  2. COAST-Y 2 yr results: In r- and nr-axSpA, IXE tx led to consistent & sustained long-term improvements in disease activity & QoL. No new safety signals. #POS0912 @uptotate

  3. Abstract #OP0137 TNFi use for at least 1 year decreased radiographic sacroiliitis progression  in early AxSpA in this ten year multicenter study of the German Spondyloarthritis Inception cohort (GESPIC).  This effect becomes evident  2-4 years after Tx.  @MeralElRamahiMD

  4. 5 cases of single-dermatome Herpes Zoster in 4 patients treated w/ UPA 15 mg QD for active AS in SELECT-AXIS 1  Medium starDo not forgot to vaccinate patients with 1st dose of Shingrix prior to starting a JAK-i. 2nd dose can be given after start of therapy.  OP0144 @MeralElRamahiMD

  5. Efficacy & Safety of UPA in AS, after 1yr from SELECT-AXIS 1 study? 187 bDMARD-naive, active AS pts w/ inadeq resp to NSAID. 82-85% txed w/ UPA 15mg QD achieved BASDAI50 or ASDAS LDA over 64 wks.  No new safety signals & ZERO VTE, MACE, TB, or deaths w/ UPA.  OP0144  @MeralElRamahiMD 

  6. Filgotinib showed a decrease in spinal inflammation of AS pts after 12 weeks!  Imaging- Subscores of the posterior elements, facet joints and vertebral bodies showed significant changes AND significant changes in spine fat, bone erosion or new bone formation. Abs#OP0141  @doctorRBC

  7. In the ESPOIR cohort of 813 RA followed for 10 years, polypharmacy  associated w/ less DAS28 ESR Remission at 5 (45.0% in vs. 56.3% (p=0.03)) and 10 yrs (32.5% vs. 67.5% (p=0.06)) BUT no longer significant when adjusted for comorbidities! #OP0098. @AurelieRheumo

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

Disclosures
The author has no conflicts of interest to disclose related to this subject